Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Clinical outcomes of fidaxomicin vs oral vancomycin in recurrent Clostridium difficile infection.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical outcomes of fidaxomicin vs oral vancomycin in recurrent Clostridium difficile infection.
Clinical outcomes of fidaxomicin vs oral vancomycin in recurrent Clostridium difficile infection. J Clin Pharm Ther. 2019 Apr; 44(2):220-228.
View in:
PubMed
subject areas
Administration, Oral
Administration, Oral
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Anti-Bacterial Agents
Anti-Bacterial Agents
Clostridium Infections
Clostridium Infections
Female
Female
Humans
Humans
Logistic Models
Logistic Models
Male
Male
Middle Aged
Middle Aged
Multivariate Analysis
Multivariate Analysis
Recurrence
Recurrence
Retrospective Studies
Retrospective Studies
Treatment Failure
Treatment Failure
Treatment Outcome
Treatment Outcome
Vancomycin
Vancomycin
authors with profiles
Grant H Skrepnek